Nanotechnology Tools for Infections Control

Nanotechnology Tools for Infections Control

Scanning New Horizons on Next-Generation Therapies to Eradicate Pathogens and Fight Drug Resistance

1st Edition - November 1, 2022

Write a review

  • Editors: Alessandro Poma, Loris Rizzello
  • Paperback ISBN: 9780128239940

Purchase options

Purchase options
Available for Pre-Order
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order


Nanotechnology Tools for Infections Control: Scanning New Horizons on Next-Generation Therapies to Eradicate Pathogens and Fight Drug Resistance provides an overview of recent strategies to build nanotechnology platforms, with a specific focus on biocompatible and biodegradable nanosystems. Particular attention is given to responsive nanoparticles, which are able to sense and respond to specific external stimuli (e.g., temperature, pH). The book includes details of the rationale behind the design of the raw materials, synthetic procedures and characterization techniques. It also introduces a new generation of nanomaterials, commonly named as ‘nanobots’, which are able to self-propel in response to external stimuli. Subsequent sections of the book focus on the applications of nanosystems as an alternative approach to standard antibiotics. The chapters describe their pharmokinetic and dynamics within the body, their ability to cross biological barriers and how they distribute within different body compartments. In this respect, a dedicated section highlights the crucial role of the immune system, as well as of protein corona, in changing the nanoparticles retention within the body. Coverage is also given to describe how nanosystems access different cells and their intracellular trafficking.

Key Features

  • Provides an overview of the current challenges in infection and immunity, showing how nanosystems can be used to meet them
  • Focuses on the translational potential of nanotechnology for both clinical and commercial applications
  • Assesses the major challenges of effectively using nanotechnology in immunology


Materials Scientists and Engineers / Micro- and Nanotechnologies; Fundamental Life Sciences / Immunology

Table of Contents

  • Section 1. The Global Context
    1. Pandemic diseases: what are the current global health challenges?
    2. Antimicrobial drug resistance - a clinical perspective and current available solutions
    3. The significant drain in antimicrobial discovery by pharma companies

    Section 2. Nanosystems – ‘How To’
    4. Nanoparticles design for infection control
    5. Nanoparticles production for infection control
    6. Nanoparticles characterisation and standardisation

    Section 3. The Nano-Challenge
    7. Principle of body navigation of nanosystems
    8. The immune system and how to avoid body clearance
    9. The problem of protein corona
    10. Intracellular fate of nanosystems, their degradation and body accumulation

    Section 4. Antimicrobial Nanosystems
    11. State of the art and potential health and environmental risks
    12. Molecular targets and pharmacodynamics for bactericidal and bacteriostatic activity
    13. How to fight bacteria without inducing drug resistance

    Section 5. The clinical drive
    14. Pre-clinical characterisation: which animal model is best for infection?
    15. Clinical translation of nanoparticles: why is it so difficult?
    16. Envisioned impact of nanotech for infection control: economy, government policy and public awareness
    17. Concluding remarks - What next?

Product details

  • No. of pages: 300
  • Language: English
  • Copyright: © Elsevier 2022
  • Published: November 1, 2022
  • Imprint: Elsevier
  • Paperback ISBN: 9780128239940

About the Editors

Alessandro Poma

Dr Alessandro Poma is a lecturer in Biomaterials and Allied Subjects in the Division of Biomaterials and Tissue Engineering , Eastman Dental Institute, University College London, UK. His research interests are solid-phase synthesis and applications of MIP NPs able to perform as “synthetic antibodies”; the synthesis of MIP NPs as non-animal antibodies substitutes for influenza virus detection and polymeric systems for drug delivery and biological applications.

Affiliations and Expertise

Lecturer, Biomaterials and Allied Subjects. Division of Biomaterials and Tissue Engineering, Eastman Dental Institute, University College London, UK.

Loris Rizzello

Dr Loris Rizzello is a Marie Curie Fellow at the Institute for Bioengineering of Catalonia (IBEC), Spain. His research interests are in the field of nanobioengineering, such as nanotechnology tools for antibacterial materials, nanosilver-based antibacterial drugs and devices.

Affiliations and Expertise

Senior Researcher , Nanobioengineering department, Institute of Bioengineering in Catalonia, Barcelona, Spain.

Ratings and Reviews

Write a review

There are currently no reviews for "Nanotechnology Tools for Infections Control"